Kyverna Therapeutics Ratios (2023-2026) | KYTX

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter) 232.59M376.55M351.16M321.92M282.65M243.58M206.83M240.49M275.43M
Equity Average (Quarter) -90.90M-104.50M-62.47M173.93M347.25M318.11M284.65M245.30M204.19M168.16M192.11M213.93M
Invested Capital (Quarter) -84.61M-97.19M-111.81M-13.14M360.99M333.51M302.71M266.59M224.01M184.38M151.95M232.28M195.58M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -260.11-289.17-325.64-454.83-667.23-857.31-0.00M-0.00M-0.00M-0.00M-0.01M-88.47-62.02
Debt to Equity (Quarter) 0.110.13
Debt Ratio (Quarter) 0.080.10
Equity Ratio (Quarter) -0.170.930.920.890.880.860.810.810.790.76
Times Interest Earned (Quarter) -260.11-289.17-325.64-454.83-667.23-857.31-0.00M-0.00M-0.00M-0.00M-0.01M-88.47-62.02
Valuation
Enterprise Value (Quarter) -39.79M-53.43M-22.97M-57.54M-369.79M-346.24M-321.59M-285.98M-242.65M-210.34M-171.16M-279.25M-232.95M
Return Ratios
Return on Capital Employed (Quarter) -38.12%-28.45%-38.40%-49.49%-64.43%-84.22%-99.21%-83.25%-66.65%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%
Return on Equity (Quarter) 0.01%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%